z-logo
open-access-imgOpen Access
Admission Glucose and Effect of Intra-Arterial Treatment in Patients With Acute Ischemic Stroke
Author(s) -
Elizabeth Osei,
Heleen M. den Hertog,
Olvert A. Berkhemer,
Puck Fransen,
Yvo B.W.E.M. Roos,
Debbie Beumer,
Robert J. van Oostenbrugge,
Wouter J. Schonewille,
Jelis Boiten,
Adrienne A.M. Zandbergen,
Peter J. Koudstaal,
Diederik W.J. Dippel
Publication year - 2017
Publication title -
stroke
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.397
H-Index - 319
eISSN - 1524-4628
pISSN - 0039-2499
DOI - 10.1161/strokeaha.116.016071
Subject(s) - medicine , ischemic stroke , stroke (engine) , cardiology , diabetes mellitus , ischemia , mechanical engineering , engineering , endocrinology
Hyperglycemia on admission is common after ischemic stroke. It is associated with unfavorable outcome after treatment with intravenous thrombolysis and after intra-arterial treatment. Whether hyperglycemia influences the effect of reperfusion treatment is unknown. We assessed whether increased admission serum glucose modifies the effect of intra-arterial treatment in patients with acute ischemic stroke.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom